Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC28922 | Nitrosobiotin |
Nitrosobiotin is prepared from biotin.
More description
|
![]() |
DC28913 | Glycosidase-IN-2 |
Glycosidase-IN-2 (Compound 20) is an azasugar class of glycosidase inhibitor. Glycosidase-IN-2 has hypoglycemic activity.
More description
|
![]() |
DC28912 | β-glycosidase-IN-1 |
β-glycosidase-IN-1 (Compound 33) is a piperidine derivative and a β-glycosidase inhibitor. β-glycosidase-IN-1 has hypoglycemic activity.
More description
|
![]() |
DC28911 | Glycosidase-IN-1 |
Glycosidase-IN-1 (Compound 9) is a glycosidase inhibitor synthesized from D-mannose. Glycosidase-IN-1 be used to synthesize some immunosuppressive agents and β-glucosidase inhibitors. Glycosidase-IN-1 has hypoglycemic activity.
More description
|
![]() |
DC28898 | Biotin-probe 1 |
Biotin-probe 1 is a non-radiolabeled probe. Biotin-labeled probes can be applied to in situ hybridization.
More description
|
![]() |
DC28897 | TAMRA-probe 1 |
TAMRA-probe 1 is a commonly used fluorescent probe for labeling.
More description
|
![]() |
DC28896 | Alkyne-probe 1 |
Alkyne-probe 1 is usually used as a Alkyne-labeled chemical or fluorescent probe.
More description
|
![]() |
DC28895 | Imatinib Acid |
Imatinib Acid, an analogue of Imatinib, is usually used as a labeled chemical or fluorescent probe.
More description
|
![]() |
DC28894 | Nilotinib Acid |
Nilotinib Acid, an analogue of Nilotinib, is usually used as a labeled chemical or fluorescent probe.
More description
|
![]() |
DC28893 | Ponatinib Acid |
Ponatinib Acid, an analogue of Ponatinib, is usually used as a labeled chemical or fluorescent probe.
More description
|
![]() |
DC28892 | ABL-001-Amide-PEG3-acid |
ABL-001-Amide-PEG3-acid, an analogue of ABL-001, is usually used as a labeled chemical or fluorescent probe.
More description
|
![]() |
DC28891 | GNF-2-PEG-acid |
GNF-2-PEG-acid, an analogue of GNF-2, is usually used as a labeled chemical or fluorescent probe.
More description
|
![]() |
DC28886 | Raloxifene dimethyl ester hydrochloride |
Raloxifene dimethyl ester hydrochloride is an analog of Raloxifene, extracted from patent US5464845A, compound 28.
More description
|
![]() |
DC28883 | LY88074 analog 1 |
LY88074 analog 1 is a benzothiophene compound with nitrogen-containing non-basic side chains, Compound 26, extracted from patent EP0747380A1. LY88074 analog 1 is an agent for alleviating the symptoms of post-menopausal symptoms, such as osteoporosis, cardiovascular related pathological conditions, and estrogen-dependent cancer. LY88074 analog 1 can be used alone or in combination with estrogen or progestin.
More description
|
![]() |
DC28882 | LY88074 Methyl ether |
LY88074 Methyl ether (Example 2) is useful for the inhibition of the various estrogen deficient conditions, which are associated with estrogendeprivation syndrome including osteoporosis and hyperlipidemia.
More description
|
![]() |
DC28881 | Methyl Raloxifene 4'-(2,3,4-Tri-O-acetyl-β-D-glycopyranuronate) |
Methyl Raloxifene 4'-(2,3,4-Tri-O-acetyl-β-D-glycopyranuronate) is an analogue of Raloxifene 4'-glucuronide.
More description
|
![]() |
DC28879 | 7-[4-(2-Piperidinyl)ethoxy]benzoyl Raloxifene |
7-[4-(2-Piperidinyl)ethoxy]benzoyl Raloxifene is a liver receptor homolog-1 (LRH-1) antagonist with an IC50 of 3.1 μM.
More description
|
![]() |
DC28878 | Raloxifene 6,4'-Bis-β-D-glucuronide |
Raloxifene 6,4'-Bis-β-D-glucuronide (compound IV) is a metabolite of Raloxifene. Raloxifene is a selective estrogen receptor antagonist for the prevention of osteoporosis.
More description
|
![]() |
DC28877 | 4'-tert-Butyldimethylsilyl-6-hydroxy Raloxifene |
4'-tert-Butyldimethylsilyl-6-hydroxy Raloxifene (Compound 4) is a reaction product of Raloxifene with tertbutyldimethylsilyl chloride. 4'-tert-Butyldimethylsilyl-6-hydroxy Raloxifene is used to synthesize Raloxifene 6-glucuronide.
More description
|
![]() |
DC28875 | LY88074 |
LY88074 (Compound 88074) is a Raloxifene analog lacking the basic side chain. Raloxifene is a selective estrogen receptor modulator, and reduces fracture risk at least in part by improving the mechanical properties of bone in a cell- and estrogen receptor-independent manner.
More description
|
![]() |
DC28873 | LY88074 Trimethyl ether |
LY88074 Trimethyl ether (Example 1) is useful for the inhibition of the various estrogen deficient conditions, which are associated with estrogen deprivation syndrome including osteoporosis and hyperlipidemia.
More description
|
![]() |
DC28870 | Raloxifene Bismethyl Ether hydrochloride |
Raloxifene Bismethyl Ether hydrochloride is a metabolite of Raloxifene and an estrogen receptor inactive compound on which both hydroxyl groups are absent.
More description
|
![]() |
DC28869 | Raloxifene Bismethyl Ether |
Raloxifene Bismethyl Ether is a metabolite of Raloxifene and an estrogen receptor inactive compound on which both hydroxyl groups are absent.
More description
|
![]() |
DC28858 | ABZ-amine |
ABZ-amine (Amino albendazole) is an impurity of Albendazole. Albendazole is a member of the benzimidazole compounds used as a drug indicated for the treatment of a variety of worm infestations.
More description
|
![]() |
DC28856 | (3R,5R)-Rosuvastatin Lactone |
(3R,5R)-Rosuvastatin Lactone is an isomer of Rosuvastatin Lactone.
More description
|
![]() |
DC28855 | 4-Acetylsimvastatin |
4-Acetylsimvastatin is an acetylated simvastatin. Simvastatin is a competitive inhibitor of HMG-CoA reductase with a Ki of 0.2 nM.
More description
|
![]() |
DC28854 | Anhydrosimvastatin |
Anhydrosimvastatin (Impurity C) is an impurity of Simvastatin. Simvastatin is a competitive inhibitor of HMG-CoA reductase.
More description
|
![]() |
DC28849 | Decarboxy Moxifloxacin |
Decarboxy Moxifloxacin (compound 8) is a decarboxylated compound of Moxifloxacin. Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia.
More description
|
![]() |
DC28848 | (R)-Linezolid |
(R)-Linezolid is an impurity of Linezolid (PNU-100766). Linezolid, the first member of the class of oxazolidinone synthetic antibiotic, acts by inhibiting the initiation of bacterial protein synthesis.
More description
|
![]() |
DC28836 | (Z)-Pitavastatin calcium |
(Z)-Pitavastatin calcium is the Z-Isomer of Pitavastatin hemicacium. Pitavastatin calcium is a potent hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitor. Pitavastatin calcium inhibits cholesterol synthesis from acetic acid with an IC50 of 5.8 nM in HepG2 cells.
More description
|
![]() |